A very subdued Stephen Colbert got right to the point Wednesday night as the knowledge that Donald Trump is going to be the new president began to sink in.
“I am so glad to be with you tonight.” the Late Show host began. “I wouldn’t want to be alone right now, you know. And if you’ll be there, I’m not going anywhere, alright? What is it, four years? Four years? We’ve got four very interesting years in front of us.”
“Walking around the streets of New York today, a lot of people were a little, you know, you could see it in their eyes,” he explained. “There’s no way around it. This ….. this is what it feels like when America’s made great again. And I was wondering, and I was really hoping it would feel better, because this suuuuuuuucks.”
Watch the video below via CBS:
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.